Fahtme Abdallah
Medical · Dearborn, MINPI 1427579077
Payments from drug & device makers
Across 52 payments — averaging $51.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$801
- Boston Scientific$430
- Boehringer Ingelheim$374
- Kestra Medical Technology Services, Inc.$153
- Novo Nordisk$145
- AstraZeneca$125
- plus $656 from 8 others
What the payments were for
- Food & beverage$2,685100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $801 |
| Boston Scientific | 20 | $430 |
| Boehringer Ingelheim | 3 | $374 |
| Kestra Medical Technology Services, Inc. | 3 | $153 |
| Novo Nordisk | 2 | $145 |
| AstraZeneca | 1 | $125 |
| Altathera Pharmaceuticals LLC | 1 | $118 |
| Lilly USA, LLC | 1 | $108 |
| Bayer | 1 | $104 |
| Truvic Medical, Inc. | 1 | $100 |
| American Regent | 1 | $85 |
| Merck | 1 | $67 |
| Abbott | 2 | $62 |
| Biotissue Holdings Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$374
- LifeVest$217
- Ozempic$125
- FARXIGA$125
- Sotalol Hydrochloride$118
- WATCHMAN FLX$110
- MOUNJARO$108
- Kerendia$104
How this compares
$2,685 in reported general payments places this provider in the 80th percentile of 755 medical providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Dearborn
- Kristie GreearDearborn$10K
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$66K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
- Robert DemeesterRoyal Oak$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.